Ranbaxy launches generic Omeprazole capsules - July 29 , 2008

Ranbaxy Laboratories on July 28 said it has launched the generic version of Omeprazole capsules, used in the treatment of acid related diseases in the US healthcare system. Ranbaxy Pharmaceuticals Inc (RPI), the wholly-owned subsidiary of Ranbaxy Laboratories under an agreement with AstraZeneca Pharmaceuticals has launched an authorised generic of Omeprazole 40 mg capsules in the US.

RPI welcome the opportunity to market an authorized generic of Omeprazole 40 mg capsules that will be commercialised immediately to all classes of trade in the US healthcare system under Ranbaxy lebel. RPI is engaged in the sale and distribution of generic and branded prescription products in the US healthcare system.

Thermax Inks 15yr Agreement With US Firm

Mumbai: Pune-based power equipment maker Thermax has forayed into a technical collaboration with Babcock & Wilcox Power Generation Group (B&W PGG), to enter into manufacturing and supply of utility boilers of up to 800 mw used to power thermal plants. The deal gives Thermax the right to design, manufacture and sell subcritical B&W Radiant utility boilers in India. The 15-year pact with B&W PGG will help Thermax to join other companies such as BHEL and the L&T-Mitsubishi combine and about five Chinese power equipment manufacturers operating in India. Thermax, which earned a revenues of Rs 2,800 crore in the first nine months of financial year 2007-08, hopes to generate Rs 1,500 crore annually from the business, tapping 10 per cent of an estimated 100,000 mw of installed capacity to come up in India in the next five years.